Home

About Us

Magazine Issues

Featured Articles

Our Authors

Family Favorites

Advertise

Subscribe

Dr. Todd Rozycki graduated from the University of Notre Dame, earned his MD degree from Indiana University School of Medicine, completed an internship in Transitional Medicine at Clarian Methodist Hospital in Indianapolis followed by a three-year residency in Dermatology at Mayo Clinic, Rochester, MN. He has practiced at the South Bend Clinic since 2002 and teaches dermatology at IU School of Medicine - South Bend. Dr. Rozycki has great interest and extensive experience in skin cancer diagnosis and treatment, laser skin surgery and cosmetic dermatology.

Click here to view more articles by this author

Nonmelanoma skin cancer

Skin cancer is a disease state where malignant skin cells begin to grow in the topmost layer of the skin (the epidermis) and give rise to tumors that can cause significant morbidity and in some cases, mortality. The United States is currently experiencing a skin cancer epidemic, with continued increases in skin cancer incidence rates over the last multiple decades, and a significant mortality rate due mostly to melanoma.

Skin cancer is generally divided into melanoma and nonmelanoma types. Melanoma arises from pigment-creating cells called melanocytes and can become locally and distantly aggressive with mortality corresponding to the stage that it is detected. Nonmelanoma skin cancer is comprised of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) and to a very minor extent, other rare malignancies. They are vastly more common than melanoma, however many people are unfamiliar with these skin cancers.

BCC

The most common malignancy in humans, BCC develops in greater than one million people every year in the United States. Approximately 80% of all skin cancers are BCC, a cancer that develops in the basal cells (lowest layer in the epidermis). BCC may have several appearances at the time it is detected: 1) a shiny translucent or pearly nodule, 2) a sore that continuously heals and then re-opens, 3) a pink slightly elevated growth, 4) reddish irritated patches of skin, or 5) a scar-like growth. Most basal cell cancers appear on skin with a history of exposure to the sun, such as the face, scalp, ears and upper trunk. These cancers tend to be very slow-growing and spread internally only very rarely, but dermatologists encourage early detection to minimize disruption and risk to the surrounding skin.

SCC

About 16% of diagnosed skin cancers are SCC, with about 200,000 new cases per year. This cancer begins in the squamous cells, which are found in the upper layer of the epidermis. SCC tends to develop in light-skinned, middle-aged and elderly people who have had significant, long-term sun exposure. SCC often appears as: 1) a crusted or scaly, inflamed nodule, 2) a non-healing ulcer, or 3) a crusted-over patch of skin. While most commonly found on sun-exposed areas of the body, it can develop anywhere, including the inside of the mouth and the genitals. SCC may arise from precancerous, flaky or scaly, pink patches called actinic keratoses. Early treatment is advised, as aggressive or neglected SCC may metastasize (spread internally).

Causes and Affected Persons

There is significant evidence that ultraviolet light (UV) causes skin cancer. UV light damages DNA of our skin cells, which may lead to mutations and ultimately, malignant change in affected cells. Humans with less pigment (melanin) such as blonds, redheads and fair-skinned people cannot retard these damaging rays from exerting their dangerous effects. Extensive or repeated exposure to UV from the sun or a tanning bed significantly raises one's risks for developing skin cancer. Additionally, a strong family history of skin cancer or a weakened immune system (immunocompromised) may lead to increased risk for BCC or SCC.

The Statistics

It is estimated that one in five Americans will develop a skin cancer in his/her lifetime. Well over one million skin cancers are predicted to occur in Americans in 2008. Thousands of people die from skin cancer every year, however, most will due to melanoma. The costs of treating nonmelanoma skin cancer exceed $1 billion annually in the U.S.

Treatment

The treatment of nonmelanoma skin cancer varies with the tumor type, size, location, patient health and age. Dermatologists/dermasurgeons use techniques as varied as local chemotherapy creams, curettage (scraping), excision, cryosurgery (freezing), laser surgery or Mohs surgery (a specialized surgical removal with frozen pathology) to treat skin cancers.

Prevention

The two most effective ways to prevent skin cancer from occurring or causing significant morbidity are: 1) limiting UV exposure to the skin and 2) checking the skin regularly for changes or suspicious areas. Regular use of broad-spectrum (UVA and UVB light blocking) sunscreens with SPF at least 30 or higher, avoidance of midday sun (10 am to 4pm), avoidance of tanning bed use, and wearing clothing designed to block UV are all effective ways to limit UV. Surveying your own skin, or having a loved one survey your skin may be helpful to detecting suspicious areas. Reporting skin changes to a physician and most specifically, a dermatologist is always advised. Having a regular dermatologist skin evaluation is a helpful tool to detect and treat skin cancer.

Free skin cancer screenings occur in our area several times through the year. Patients with concerns over suspicious areas or wanting to establish regular dermatologist-performed skin exams are encouraged to make an appointment.

 

Michiana Family Magazine
Phone (574) 293-FAM1 (3261) • Fax (866) 745-6246
Media@Michianafamilymagazine.com • 530 E. Lexington Avenue Suite 100C Elkhart, IN 46516

Home | About Us | Magazine Issues |Featured Articles | Our Authors | Family Favorites | Advertise | Subscribe